Dan Roden

June 12, 2014

Roden named to NIH’s genomics advisory council

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

By Bill Snyder
August 15, 2013

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

By Bill Snyder
June 13, 2013

Clinical Pharmacology celebrates 50th anniversary

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.

By Bill Snyder
November 29, 2012

Record number elected AAAS fellows

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.

By Bill Snyder
November 15, 2012

Heart Association honors Roden’s research efforts

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.

By Kathy Whitney
September 27, 2012

AAMC meet highlights need for research funds

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.

By Bill Snyder
September 6, 2012

Personalized medicine focus of Chancellor’s Lecture

The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.
By Bill Snyder
September 6, 2012

BioVU reaches new benchmark in DNA samples

This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information.
By Bill Snyder
August 10, 2012

Key to a woman’s heart (condition)?

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.
By VUMC News and Communications
February 22, 2012

Next My Health Chat: ‘Your Genome and the Future of Medicine’

By VUMC News and Communications
December 6, 2011

Study points to personal treatment for atrial fibrillation

Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy.
By Kathy Whitney
October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
By Craig Boerner
April 15, 2011

Vanderbilt: Laboratory for health care reform

By Bill Snyder